Monitoring thrombin generation by electrochemistry: Development of an amperometric biosensor screening test for plasma and whole blood

Clinical Chemistry

Volumn 55, Issue 3, 2009, Pages 505-512

  Thuerlemann, Charles ^a   Haeberli, André ^a   Alberio, Lorenzo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; REAGENT; SILICON DIOXIDE; THROMBIN; THROMBOPLASTIN;

AMPEROMETRIC BIOSENSOR; ARTICLE; ASSAY; BLOOD; BLOOD CLOTTING; BLOOD SAMPLING; COLOR; CONCENTRATION (PARAMETERS); ELECTRIC ACTIVITY; ELECTROCHEMISTRY; MEASUREMENT; MICROCOMPUTER; MONITORING; RECORDING; SCREENING TEST; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; TURBIDITY; BLOOD ANALYSIS; CHEMISTRY; GENETIC PROCEDURES; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY;

BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; ELECTROCHEMISTRY; HUMANS; THROMBIN;

EID: 62149152387     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.111963     Document Type: Article

References (18)

1. Merlini G, Stone MJ. Dangerous small B-cell clones. Blood 2006;108:2520-30.
2. Merlini G, Palladini G. Amyloidosis: Is a cure possible? Ann Oncol 2008;19 Suppl 4:iv63-6.
3. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th international symposium on amyloid and amyloidosis, Tours, France, April 18-22, 2004. Am J Hematol 2005; 79:319-28.
4. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and char- acterizes amyloid fibrils in suspected cardiac amy- loidosis. Amyloid 2002;9:108-14.
5. Jeppsson JO, Laurell CB, Franzén B. Agarose gel electrophoresis. Clin Chem 1979;25:629-38.
6. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44.
7. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burrit MF, Therneau TM, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-7.
8. Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, et al. Serum free light chain measurement aids the diagnosis of my- eloma in patients with severe renal failure. BMC Nephrol 2008;9:11.
9. Lachmann HJ, Gallimore R, Gillmore JD, Carr- Smith HD, Bradwell AR, Pepys MB, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglob- ulin light chains following chemotherapy. Br J Haematol 2003;122:78-84.
10. Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA. Quantitative analysis of serum free light chains: a new marker for the diagnostic evaluation of primary systemic amy- loidosis. Am J Clin Pathol 2003;119:274-8.
11. Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, et al. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid 2005;12:210-5.
12. Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA. Diagnostic performance of quantita- tive kappa and lambda free light chain assays in clinical practice. Clin Chem 2005;51:878-81.
13. Bochtler T, Hegenbart U, Heiss C, Benner A, Cremer F, Volkmann M, et al. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis. Haematologica 2008;93: 459-62.
14. Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, et al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc 2006;81:1575-8.
15. Nowrousian MR, Brandhorst D, Sammet C, Kellert M, Daniels R, Schuett P, et al. Serum free light chain analysis and urine immunofixation electro- phoresis in patients with multiple myeloma. Clin Cancer Res 2005;11:8706-14.
16. Hill PG, Forsyth JM, Rai B, Mayne S. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 2006;52:1743-8.
17. Piehler AP, Gulbrandsen N, Kierulf P, Urdal P. Quantitation of serum free light chains in combi- nation with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population. Clin Chem 2008;54: 1823-30.
18. Dispenzieri A, Zhang L, Katzmann JA, Snyder M, Blood E, Degoey R, et al. Appraisal of immuno- globulin free light chain as a marker of response. Blood 2008;111:4908-15.